CeMines

Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of CeMines plus 5271 other startups.